Global Rasagiline Tablet

Rasagiline Tablet Comprehensive Study by Type (0.5 mg Tablet, 1 mg Tablet, Others), Application (Clinics and Hospital, Households, Caring Center, Others), Distribution Channel (Online Channels, Offline Channels) Players and Region - Global Market Outlook to 2026

Rasagiline Tablet Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Rasagiline Tablet Market?

It is estimated that seven to 10 million people around the world have Parkinson's disease. Rasagiline is a monoamine oxidase-B (MAO-B) inhibitor used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as stiffness, shakiness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).

The market study is being classified by Type (0.5 mg Tablet, 1 mg Tablet and Others), by Application (Clinics and Hospital, Households, Caring Center and Others) and major geographies with country level break-up.

Orchid Pharma Ltd. (India), Teva Pharmaceuticals (Israel), Apotex Inc. (Canada), Taj Pharmaceuticals (India), Sigma-Aldrich (United States), Cayman Chemical Company (United States), Tocris Bioscience (United Kingdom) and Accord Healthcare Ltd. (India) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Rasagiline Tablet market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Rasagiline Tablet market by Type, Application and Region.

On the basis of geography, the market of Rasagiline Tablet has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Number of Hospitals and Clinics

Market Trend
  • Increased Patient Awareness about Healthy Lifestyle
  • Rise in the Number of Online Customers

Restraints
  • Side Effects of the Rasagiline Tablet

Opportunities
  • Growing Demand from End-users
  • Growth in the Healthcare Sector

Challenges
  • Stringent Government Rules and Regulations





Key Target Audience
Rasagiline Tablet Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users

Report Objectives / Segmentation Covered

By Type
  • 0.5 mg Tablet
  • 1 mg Tablet
  • Others
By Application
  • Clinics and Hospital
  • Households
  • Caring Center
  • Others
By Distribution Channel
  • Online Channels
  • Offline Channels

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Hospitals and Clinics
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Patient Awareness about Healthy Lifestyle
      • 3.4.2. Rise in the Number of Online Customers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rasagiline Tablet, by Type, Application, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Rasagiline Tablet (Value)
      • 5.2.1. Global Rasagiline Tablet by: Type (Value)
        • 5.2.1.1. 0.5 mg Tablet
        • 5.2.1.2. 1 mg Tablet
        • 5.2.1.3. Others
      • 5.2.2. Global Rasagiline Tablet by: Application (Value)
        • 5.2.2.1. Clinics and Hospital
        • 5.2.2.2. Households
        • 5.2.2.3. Caring Center
        • 5.2.2.4. Others
      • 5.2.3. Global Rasagiline Tablet by: Distribution Channel (Value)
        • 5.2.3.1. Online Channels
        • 5.2.3.2. Offline Channels
      • 5.2.4. Global Rasagiline Tablet Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Rasagiline Tablet (Volume)
      • 5.3.1. Global Rasagiline Tablet by: Type (Volume)
        • 5.3.1.1. 0.5 mg Tablet
        • 5.3.1.2. 1 mg Tablet
        • 5.3.1.3. Others
      • 5.3.2. Global Rasagiline Tablet by: Application (Volume)
        • 5.3.2.1. Clinics and Hospital
        • 5.3.2.2. Households
        • 5.3.2.3. Caring Center
        • 5.3.2.4. Others
      • 5.3.3. Global Rasagiline Tablet by: Distribution Channel (Volume)
        • 5.3.3.1. Online Channels
        • 5.3.3.2. Offline Channels
      • 5.3.4. Global Rasagiline Tablet Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Rasagiline Tablet (Price)
      • 5.4.1. Global Rasagiline Tablet by: Type (Price)
  • 6. Rasagiline Tablet: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Orchid Pharma Ltd. (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceuticals (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Apotex Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Taj Pharmaceuticals (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sigma-Aldrich (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cayman Chemical Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tocris Bioscience (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Accord Healthcare Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Rasagiline Tablet Sale, by Type, Application, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Rasagiline Tablet (Value)
      • 7.2.1. Global Rasagiline Tablet by: Type (Value)
        • 7.2.1.1. 0.5 mg Tablet
        • 7.2.1.2. 1 mg Tablet
        • 7.2.1.3. Others
      • 7.2.2. Global Rasagiline Tablet by: Application (Value)
        • 7.2.2.1. Clinics and Hospital
        • 7.2.2.2. Households
        • 7.2.2.3. Caring Center
        • 7.2.2.4. Others
      • 7.2.3. Global Rasagiline Tablet by: Distribution Channel (Value)
        • 7.2.3.1. Online Channels
        • 7.2.3.2. Offline Channels
      • 7.2.4. Global Rasagiline Tablet Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Rasagiline Tablet (Volume)
      • 7.3.1. Global Rasagiline Tablet by: Type (Volume)
        • 7.3.1.1. 0.5 mg Tablet
        • 7.3.1.2. 1 mg Tablet
        • 7.3.1.3. Others
      • 7.3.2. Global Rasagiline Tablet by: Application (Volume)
        • 7.3.2.1. Clinics and Hospital
        • 7.3.2.2. Households
        • 7.3.2.3. Caring Center
        • 7.3.2.4. Others
      • 7.3.3. Global Rasagiline Tablet by: Distribution Channel (Volume)
        • 7.3.3.1. Online Channels
        • 7.3.3.2. Offline Channels
      • 7.3.4. Global Rasagiline Tablet Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Rasagiline Tablet (Price)
      • 7.4.1. Global Rasagiline Tablet by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rasagiline Tablet: by Type(USD Million)
  • Figure 4. Global Rasagiline Tablet: by Type USD Million (2015-2020)
  • Table 2. Rasagiline Tablet 0.5 mg Tablet , by Region USD Million (2015-2020)
  • Table 3. Rasagiline Tablet 1 mg Tablet , by Region USD Million (2015-2020)
  • Table 4. Rasagiline Tablet Others , by Region USD Million (2015-2020)
  • Table 5. Rasagiline Tablet: by Application(USD Million)
  • Figure 5. Global Rasagiline Tablet: by Application USD Million (2015-2020)
  • Table 6. Rasagiline Tablet Clinics and Hospital , by Region USD Million (2015-2020)
  • Table 7. Rasagiline Tablet Households , by Region USD Million (2015-2020)
  • Table 8. Rasagiline Tablet Caring Center , by Region USD Million (2015-2020)
  • Table 9. Rasagiline Tablet Others , by Region USD Million (2015-2020)
  • Table 10. Rasagiline Tablet: by Distribution Channel(USD Million)
  • Figure 6. Global Rasagiline Tablet: by Distribution Channel USD Million (2015-2020)
  • Table 11. Rasagiline Tablet Online Channels , by Region USD Million (2015-2020)
  • Table 12. Rasagiline Tablet Offline Channels , by Region USD Million (2015-2020)
  • Table 13. South America Rasagiline Tablet, by Country USD Million (2015-2020)
  • Figure 7. South America Rasagiline Tablet Share (%), by Country
  • Table 14. South America Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 15. South America Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 16. South America Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 17. Brazil Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 18. Brazil Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 19. Brazil Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 20. Argentina Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 21. Argentina Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 22. Argentina Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 23. Rest of South America Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 25. Rest of South America Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 26. Asia Pacific Rasagiline Tablet, by Country USD Million (2015-2020)
  • Figure 8. Asia Pacific Rasagiline Tablet Share (%), by Country
  • Table 27. Asia Pacific Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 29. Asia Pacific Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 30. China Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 31. China Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 32. China Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 33. Japan Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 34. Japan Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 35. Japan Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 36. India Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 37. India Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 38. India Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 39. South Korea Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 40. South Korea Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 41. South Korea Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 42. Taiwan Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 43. Taiwan Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 44. Taiwan Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 45. Australia Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 46. Australia Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 47. Australia Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 51. Europe Rasagiline Tablet, by Country USD Million (2015-2020)
  • Figure 9. Europe Rasagiline Tablet Share (%), by Country
  • Table 52. Europe Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 53. Europe Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 54. Europe Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 55. Germany Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 56. Germany Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 57. Germany Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 58. France Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 59. France Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 60. France Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 61. Italy Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 62. Italy Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 63. Italy Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 64. United Kingdom Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 66. United Kingdom Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 67. Netherlands Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 68. Netherlands Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 69. Netherlands Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 70. Rest of Europe Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 72. Rest of Europe Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 73. MEA Rasagiline Tablet, by Country USD Million (2015-2020)
  • Figure 10. MEA Rasagiline Tablet Share (%), by Country
  • Table 74. MEA Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 75. MEA Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 76. MEA Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 77. Middle East Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 78. Middle East Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 79. Middle East Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 80. Africa Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 81. Africa Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 82. Africa Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 83. North America Rasagiline Tablet, by Country USD Million (2015-2020)
  • Figure 11. North America Rasagiline Tablet Share (%), by Country
  • Table 84. North America Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 85. North America Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 86. North America Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 87. United States Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 88. United States Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 89. United States Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 90. Canada Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 91. Canada Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 92. Canada Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 93. Mexico Rasagiline Tablet, by Type USD Million (2015-2020)
  • Table 94. Mexico Rasagiline Tablet, by Application USD Million (2015-2020)
  • Table 95. Mexico Rasagiline Tablet, by Distribution Channel USD Million (2015-2020)
  • Table 96. Rasagiline Tablet Sales: by Type(K Units)
  • Figure 12. Global Rasagiline Tablet: by Type K Units (2015-2020)
  • Table 97. Rasagiline Tablet Sales 0.5 mg Tablet , by Region K Units (2015-2020)
  • Table 98. Rasagiline Tablet Sales 1 mg Tablet , by Region K Units (2015-2020)
  • Table 99. Rasagiline Tablet Sales Others , by Region K Units (2015-2020)
  • Table 100. Rasagiline Tablet Sales: by Application(K Units)
  • Figure 13. Global Rasagiline Tablet: by Application K Units (2015-2020)
  • Table 101. Rasagiline Tablet Sales Clinics and Hospital , by Region K Units (2015-2020)
  • Table 102. Rasagiline Tablet Sales Households , by Region K Units (2015-2020)
  • Table 103. Rasagiline Tablet Sales Caring Center , by Region K Units (2015-2020)
  • Table 104. Rasagiline Tablet Sales Others , by Region K Units (2015-2020)
  • Table 105. Rasagiline Tablet Sales: by Distribution Channel(K Units)
  • Figure 14. Global Rasagiline Tablet: by Distribution Channel K Units (2015-2020)
  • Table 106. Rasagiline Tablet Sales Online Channels , by Region K Units (2015-2020)
  • Table 107. Rasagiline Tablet Sales Offline Channels , by Region K Units (2015-2020)
  • Table 108. South America Rasagiline Tablet Sales, by Country K Units (2015-2020)
  • Figure 15. South America Rasagiline Tablet Share (%), by Country
  • Table 109. South America Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 110. South America Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 111. South America Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 112. Brazil Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 113. Brazil Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 114. Brazil Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 115. Argentina Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 116. Argentina Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 117. Argentina Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 118. Rest of South America Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 119. Rest of South America Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 120. Rest of South America Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 121. Asia Pacific Rasagiline Tablet Sales, by Country K Units (2015-2020)
  • Figure 16. Asia Pacific Rasagiline Tablet Share (%), by Country
  • Table 122. Asia Pacific Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 123. Asia Pacific Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 124. Asia Pacific Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 125. China Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 126. China Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 127. China Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 128. Japan Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 129. Japan Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 130. Japan Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 131. India Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 132. India Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 133. India Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 134. South Korea Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 135. South Korea Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 136. South Korea Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 137. Taiwan Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 138. Taiwan Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 139. Taiwan Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 140. Australia Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 141. Australia Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 142. Australia Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 143. Rest of Asia-Pacific Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 144. Rest of Asia-Pacific Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 145. Rest of Asia-Pacific Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 146. Europe Rasagiline Tablet Sales, by Country K Units (2015-2020)
  • Figure 17. Europe Rasagiline Tablet Share (%), by Country
  • Table 147. Europe Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 148. Europe Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 149. Europe Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 150. Germany Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 151. Germany Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 152. Germany Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 153. France Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 154. France Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 155. France Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 156. Italy Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 157. Italy Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 158. Italy Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 159. United Kingdom Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 160. United Kingdom Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 161. United Kingdom Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 162. Netherlands Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 163. Netherlands Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 164. Netherlands Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 165. Rest of Europe Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 166. Rest of Europe Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 167. Rest of Europe Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 168. MEA Rasagiline Tablet Sales, by Country K Units (2015-2020)
  • Figure 18. MEA Rasagiline Tablet Share (%), by Country
  • Table 169. MEA Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 170. MEA Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 171. MEA Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 172. Middle East Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 173. Middle East Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 174. Middle East Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 175. Africa Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 176. Africa Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 177. Africa Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 178. North America Rasagiline Tablet Sales, by Country K Units (2015-2020)
  • Figure 19. North America Rasagiline Tablet Share (%), by Country
  • Table 179. North America Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 180. North America Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 181. North America Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 182. United States Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 183. United States Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 184. United States Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. Canada Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 186. Canada Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 187. Canada Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 188. Mexico Rasagiline Tablet Sales, by Type K Units (2015-2020)
  • Table 189. Mexico Rasagiline Tablet Sales, by Application K Units (2015-2020)
  • Table 190. Mexico Rasagiline Tablet Sales, by Distribution Channel K Units (2015-2020)
  • Table 191. Rasagiline Tablet: by Type(USD/Units)
  • Figure 20. Global Rasagiline Tablet: by Type USD/Units (2015-2020)
  • Figure 21. Global Rasagiline Tablet share by Players 2020 (%)
  • Figure 22. Global Rasagiline Tablet share by Players (Top 3) 2020(%)
  • Figure 23. Global Rasagiline Tablet share by Players (Top 5) 2020(%)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Rasagiline Tablet: by Type(USD Million)
  • Figure 41. Global Rasagiline Tablet: by Type USD Million (2021-2026)
  • Table 201. Rasagiline Tablet 0.5 mg Tablet , by Region USD Million (2021-2026)
  • Table 202. Rasagiline Tablet 1 mg Tablet , by Region USD Million (2021-2026)
  • Table 203. Rasagiline Tablet Others , by Region USD Million (2021-2026)
  • Table 204. Rasagiline Tablet: by Application(USD Million)
  • Figure 42. Global Rasagiline Tablet: by Application USD Million (2021-2026)
  • Table 205. Rasagiline Tablet Clinics and Hospital , by Region USD Million (2021-2026)
  • Table 206. Rasagiline Tablet Households , by Region USD Million (2021-2026)
  • Table 207. Rasagiline Tablet Caring Center , by Region USD Million (2021-2026)
  • Table 208. Rasagiline Tablet Others , by Region USD Million (2021-2026)
  • Table 209. Rasagiline Tablet: by Distribution Channel(USD Million)
  • Figure 43. Global Rasagiline Tablet: by Distribution Channel USD Million (2021-2026)
  • Table 210. Rasagiline Tablet Online Channels , by Region USD Million (2021-2026)
  • Table 211. Rasagiline Tablet Offline Channels , by Region USD Million (2021-2026)
  • Table 212. South America Rasagiline Tablet, by Country USD Million (2021-2026)
  • Figure 44. South America Rasagiline Tablet Share (%), by Country
  • Table 213. South America Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 214. South America Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 215. South America Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 216. Brazil Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 217. Brazil Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 218. Brazil Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 219. Argentina Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 220. Argentina Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 221. Argentina Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 222. Rest of South America Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 223. Rest of South America Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 224. Rest of South America Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 225. Asia Pacific Rasagiline Tablet, by Country USD Million (2021-2026)
  • Figure 45. Asia Pacific Rasagiline Tablet Share (%), by Country
  • Table 226. Asia Pacific Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 227. Asia Pacific Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 228. Asia Pacific Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 229. China Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 230. China Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 231. China Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 232. Japan Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 233. Japan Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 234. Japan Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 235. India Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 236. India Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 237. India Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 238. South Korea Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 239. South Korea Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 240. South Korea Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 241. Taiwan Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 242. Taiwan Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 243. Taiwan Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 244. Australia Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 245. Australia Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 246. Australia Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 248. Rest of Asia-Pacific Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 250. Europe Rasagiline Tablet, by Country USD Million (2021-2026)
  • Figure 46. Europe Rasagiline Tablet Share (%), by Country
  • Table 251. Europe Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 252. Europe Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 253. Europe Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 254. Germany Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 255. Germany Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 256. Germany Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 257. France Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 258. France Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 259. France Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 260. Italy Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 261. Italy Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 262. Italy Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 263. United Kingdom Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 264. United Kingdom Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 265. United Kingdom Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 266. Netherlands Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 267. Netherlands Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 268. Netherlands Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 269. Rest of Europe Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 270. Rest of Europe Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 271. Rest of Europe Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 272. MEA Rasagiline Tablet, by Country USD Million (2021-2026)
  • Figure 47. MEA Rasagiline Tablet Share (%), by Country
  • Table 273. MEA Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 274. MEA Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 275. MEA Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 276. Middle East Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 277. Middle East Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 278. Middle East Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 279. Africa Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 280. Africa Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 281. Africa Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 282. North America Rasagiline Tablet, by Country USD Million (2021-2026)
  • Figure 48. North America Rasagiline Tablet Share (%), by Country
  • Table 283. North America Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 284. North America Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 285. North America Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 286. United States Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 287. United States Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 288. United States Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 289. Canada Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 290. Canada Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 291. Canada Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 292. Mexico Rasagiline Tablet, by Type USD Million (2021-2026)
  • Table 293. Mexico Rasagiline Tablet, by Application USD Million (2021-2026)
  • Table 294. Mexico Rasagiline Tablet, by Distribution Channel USD Million (2021-2026)
  • Table 295. Rasagiline Tablet Sales: by Type(K Units)
  • Figure 49. Global Rasagiline Tablet: by Type K Units (2021-2026)
  • Table 296. Rasagiline Tablet Sales 0.5 mg Tablet , by Region K Units (2021-2026)
  • Table 297. Rasagiline Tablet Sales 1 mg Tablet , by Region K Units (2021-2026)
  • Table 298. Rasagiline Tablet Sales Others , by Region K Units (2021-2026)
  • Table 299. Rasagiline Tablet Sales: by Application(K Units)
  • Figure 50. Global Rasagiline Tablet: by Application K Units (2021-2026)
  • Table 300. Rasagiline Tablet Sales Clinics and Hospital , by Region K Units (2021-2026)
  • Table 301. Rasagiline Tablet Sales Households , by Region K Units (2021-2026)
  • Table 302. Rasagiline Tablet Sales Caring Center , by Region K Units (2021-2026)
  • Table 303. Rasagiline Tablet Sales Others , by Region K Units (2021-2026)
  • Table 304. Rasagiline Tablet Sales: by Distribution Channel(K Units)
  • Figure 51. Global Rasagiline Tablet: by Distribution Channel K Units (2021-2026)
  • Table 305. Rasagiline Tablet Sales Online Channels , by Region K Units (2021-2026)
  • Table 306. Rasagiline Tablet Sales Offline Channels , by Region K Units (2021-2026)
  • Table 307. South America Rasagiline Tablet Sales, by Country K Units (2021-2026)
  • Figure 52. South America Rasagiline Tablet Share (%), by Country
  • Table 308. South America Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 309. South America Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 310. South America Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 311. Brazil Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 312. Brazil Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 313. Brazil Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 314. Argentina Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 315. Argentina Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 316. Argentina Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 317. Rest of South America Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 318. Rest of South America Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 319. Rest of South America Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 320. Asia Pacific Rasagiline Tablet Sales, by Country K Units (2021-2026)
  • Figure 53. Asia Pacific Rasagiline Tablet Share (%), by Country
  • Table 321. Asia Pacific Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 322. Asia Pacific Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 323. Asia Pacific Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 324. China Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 325. China Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 326. China Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 327. Japan Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 328. Japan Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 329. Japan Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 330. India Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 331. India Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 332. India Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 333. South Korea Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 334. South Korea Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 335. South Korea Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 336. Taiwan Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 337. Taiwan Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 338. Taiwan Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 339. Australia Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 340. Australia Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 341. Australia Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 342. Rest of Asia-Pacific Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 343. Rest of Asia-Pacific Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 344. Rest of Asia-Pacific Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 345. Europe Rasagiline Tablet Sales, by Country K Units (2021-2026)
  • Figure 54. Europe Rasagiline Tablet Share (%), by Country
  • Table 346. Europe Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 347. Europe Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 348. Europe Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 349. Germany Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 350. Germany Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 351. Germany Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 352. France Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 353. France Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 354. France Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 355. Italy Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 356. Italy Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 357. Italy Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 358. United Kingdom Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 359. United Kingdom Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 360. United Kingdom Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 361. Netherlands Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 362. Netherlands Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 363. Netherlands Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 364. Rest of Europe Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 365. Rest of Europe Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 366. Rest of Europe Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 367. MEA Rasagiline Tablet Sales, by Country K Units (2021-2026)
  • Figure 55. MEA Rasagiline Tablet Share (%), by Country
  • Table 368. MEA Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 369. MEA Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 370. MEA Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 371. Middle East Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 372. Middle East Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 373. Middle East Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 374. Africa Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 375. Africa Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 376. Africa Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 377. North America Rasagiline Tablet Sales, by Country K Units (2021-2026)
  • Figure 56. North America Rasagiline Tablet Share (%), by Country
  • Table 378. North America Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 379. North America Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 380. North America Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 381. United States Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 382. United States Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 383. United States Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 384. Canada Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 385. Canada Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 386. Canada Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 387. Mexico Rasagiline Tablet Sales, by Type K Units (2021-2026)
  • Table 388. Mexico Rasagiline Tablet Sales, by Application K Units (2021-2026)
  • Table 389. Mexico Rasagiline Tablet Sales, by Distribution Channel K Units (2021-2026)
  • Table 390. Rasagiline Tablet: by Type(USD/Units)
  • Figure 57. Global Rasagiline Tablet: by Type USD/Units (2021-2026)
  • Table 391. Research Programs/Design for This Report
  • Table 392. Key Data Information from Secondary Sources
  • Table 393. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Orchid Pharma Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 26. Orchid Pharma Ltd. (India) Revenue: by Geography 2020
  • Figure 27. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 28. Teva Pharmaceuticals (Israel) Revenue: by Geography 2020
  • Figure 29. Apotex Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 30. Apotex Inc. (Canada) Revenue: by Geography 2020
  • Figure 31. Taj Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 32. Taj Pharmaceuticals (India) Revenue: by Geography 2020
  • Figure 33. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 34. Sigma-Aldrich (United States) Revenue: by Geography 2020
  • Figure 35. Cayman Chemical Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Cayman Chemical Company (United States) Revenue: by Geography 2020
  • Figure 37. Tocris Bioscience (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Tocris Bioscience (United Kingdom) Revenue: by Geography 2020
  • Figure 39. Accord Healthcare Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 40. Accord Healthcare Ltd. (India) Revenue: by Geography 2020
List of companies from research coverage that are profiled in the study
  • Orchid Pharma Ltd. (India)
  • Teva Pharmaceuticals (Israel)
  • Apotex Inc. (Canada)
  • Taj Pharmaceuticals (India)
  • Sigma-Aldrich (United States)
  • Cayman Chemical Company (United States)
  • Tocris Bioscience (United Kingdom)
  • Accord Healthcare Ltd. (India)
Select User Access Type

Key Highlights of Report


Sep 2021 235 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rasagiline Tablet Quantitative research analysis
Global Rasagiline Tablet Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Number of Hospitals and Clinics" is seen as one of major growth factors of Rasagiline Tablet Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Global will lead Rasagiline Tablet Market in coming years.

Know More About Global Rasagiline Tablet Report?

Have a Query? Click Here

Other Related Reports

Nasal Polyposis Drug Comprehensive Study by Route of Administration (Oral, Nasal, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Drug Class (Cortic...
$ 3650
Lymphoma Drugs Comprehensive Study by Type (Hodgkin Lymphoma (HL) Drugs, Non-Hodgkin Lymphoma (NHL) Drugs), Lymphoma Treatment Drug (Adcetris, Opdivo, Rituxan/MabThera, Imbruvica, Keytruda, Revlimid,...
$ 3450
Primary Antibodies Comprehensive Study by Type (Monoclonal Antibodies, Polyclonal Antibodies), Application (Proteomics, Drug Development, Genomics), End-users (Pharmaceutical and Biotechnological Com...
$ 3750
Anticoccidial Drugs Comprehensive Study by Type (Antibiotic Anticoccidials, Ionophore Anticoccidials, Chemical Derivative Anticoccidials), Application (Poultry, Swine, Fish, Cattle, Companion Animals...
$ 3450
Erectile Dysfunction Drugs Comprehensive Study by Type (Existing Drugs, Pipeline Drugs), Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), Pipel...
$ 3750
Tea Capsules Comprehensive Study by Type (Red Tea Capsules, Oolong Tea Capsules, Black Tea Capsules, Yellow Tea Capsules), Application (Residential, Commercial), Category (Children, Adults), Distribu...
$ 3450